Woodland Research Northwest Site # 138 — Rogers, Arkansas

Woodland Research Northwest Site # 138 is a clinical research site located in Rogers, Arkansas, United States 72758.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Woodland Research Northwest Site # 138 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Schizophrenia.

Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Woodland Research Northwest Site # 138?

Woodland Research Northwest Site # 138 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Woodland Research Northwest Site # 138 conducted?

Woodland Research Northwest Site # 138 has 1 clinical trials on record, with 1 currently active. Their work covers Schizophrenia.

Is Woodland Research Northwest Site # 138 accredited by Crixeo Health?

Woodland Research Northwest Site # 138 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Woodland Research Northwest Site # 138?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.